Insider TradingJul 21, 2026, 06:07 AM
Mesoblast CEO Itescu Exercises Options, Boosts Stake
AI Summary
Mesoblast Limited announced that CEO Dr. Silviu Itescu exercised 1,885,334 options, paying A$2,733,734. This transaction increased his total shareholding to 80,844,262 ordinary shares, reflecting his strong confidence in the company's growth and value. He did not sell any of the newly acquired shares.
Key Highlights
- CEO Dr. Silviu Itescu exercised 1,885,334 options.
- Paid A$2,733,734 for the option exercise.
- Increased total shareholding to 80,844,262 ordinary shares.
- Did not sell any newly acquired shares.
- Previous ordinary shareholding was 78,958,928.
- Remaining options after exercise: 16,311,253.
Price Impact
More from MESO